D-0763-2022 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- April 13, 2022
- Initiation Date
- March 21, 2022
- Termination Date
- February 8, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25,103 cartons
Product Description
SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02
Reason for Recall
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Distribution Pattern
Nationwide in the U.S.A.
Code Information
Lot #: 21041W, Exp. 8/31/2022; 21081W, Exp. 11/30/2022; 21102W, Exp. 2/28/2023